Prostate cancer decisions — 2024

The Veteran's claims for service connection are being remanded due to the need for additional medical opinions regarding the relationship between his claimed conditions and active service, including exposure to herbicide agents and asbestos.

The Veteran's claims for glaucoma and temporomandibular joint dysfunction have been dismissed as the Veteran withdrew these claims during a hearing.,New evidence has reopened previously denied claims for tinnitus, an acquired psychiatric disability (including PTSD), congestive heart failure, atrial fibrillation, COPD, chronic renal insufficiency, hypertension, prostate cancer, bilateral hearing loss, left knee disability, and right knee disability.

The Veteran withdrew his appeal regarding the disability rating for his service-connected prostate cancer residuals.

The Veteran's residuals of prostate cancer, which resulted in voiding dysfunction causing urine leakage requiring the changing of absorbent materials more than four times per day, are now rated at 60 percent effective December 1, 2019.

The Veteran's cause of death is granted due to the PACT Act, and service connection for bladder cancer is remanded.

The Veteran's prostate cancer with insomnia is rated at 20 percent from February 22, 2019, to August 10, 2022, and 20 percent after that date. The issues of service connection for ED and loss of use of a creative organ are remanded.,The effective dates for the prostate cancer rating and SMC based on loss of use of a creative organ are denied as they predate February 22, 2019.

The Board denied the Veteran's claims for service connection for hypertension, prostate cancer, and hypothyroidism due to a lack of evidence showing exposure to herbicide agents during service or direct causation.

The Veteran's erectile dysfunction is not associated with a penile deformity, and he does not meet the criteria for an initial compensable rating under Diagnostic Code 7522.

The Veteran's claims for compensation under 38 U.S.C. § 1151 for prostate cancer and service connection for obstructive sleep apnea (OSA) are remanded due to the need for additional medical opinions regarding the relationship between his service-connected PTSD and these conditions.

The Board has found a pre-decisional duty to assist error and remands the case for further action, including verifying the Veteran's alleged toxic exposures during service.

The Board has decided to remand the case due to a duty-to-assist error in failing to obtain an adequate VA examination regarding service connection for prostate cancer. The Veteran's claim is being returned to the AOJ for further action.

The Board has granted service connection for prostate cancer, finding that the Veteran's exposure to toxic chemicals at Fort Polk, Louisiana is likely linked to his current condition.

The Board has remanded the case due to concerns about the adequacy of the June 2022 VA prostate examination, which was conducted by a physician's assistant in general medicine. The Veteran's representative requested that VA provide the CV and other information about the qualifications of the examiner who performed the exam.

The Veteran's initial rating for residuals of prostate cancer, prior to March 21, 2018, is granted at a 20 percent rating.,From March 21, 2018, the Veteran's disability is rated at a 40 percent rating based on nighttime voiding five or more times per night.

The Board has determined that additional development is necessary prior to final adjudication of the service connection claim for prostate cancer, including consideration of herbicide exposure. The case is REMANDED for further clarification and evaluation.

The Board has granted service connection for prostate cancer residuals, coronary artery disease, and diabetes on a presumptive basis due to herbicide agent exposure during active duty at Fort Gordon.

The Veteran's prostate cancer is related to his herbicide exposure in Vietnam and service connection for the condition has been granted.

The Board has granted a 100% rating for service-connected prostate cancer effective from November 21, 2019. The Veteran's active prostate cancer was confirmed by MRI and biopsy on that date.

The Veteran's appeal for service connection for sleep apnea was withdrawn. The claims of increased rating for left shoulder disability, recurrent dislocation of the left shoulder, and left ankle sprain were denied. Service connection for asthma, GERD, acquired psychiatric disability (including PTSD and adjustment disorder), prostate cancer, and emphysema were all denied.

The Veteran's claims for service connection for prostate cancer and PTSD are being remanded due to pre-decisional duty to assist errors. He needs VA examinations to determine the nature and etiology of his diagnosed conditions.